Eglucent 100IU Cartridge 5x3 ml

babies: this medicine is not safe to use in <3 year-old children. lactating mother: this medicine is safe to use in lactating mothers.
limited human studies have shown that this medicine doe not cause any harm to the baby. pregnancy: this medicine is safe to use in pregnancy.
available studies on animals have shown that it does not cause any harm to the developing baby. alcohol: this medicine is not safe to use while consuming alcohol.
driving: this medicine may affect your ability to drive. avoid driving if you have any symptoms.
kidney: this medicine should be used with caution in patients with kidney disease. dose adjustment may be necessary.
seek your doctor's advice before using this medication. regular monitoring is necessary for dose adjustment.
liver: this medicine should be used with caution in patients with liver disease. dose adjustment may be necessary.
seek your doctor's advice before using this medication. regular monitoring is necessary for dose adjustment..

hypoglycemia injection site allergic reaction lipodystrophy itching rash allergic reaction.

eglucent is an anti-diabetic medication. eglucent prevents hepatic glucose generation and lowers blood sugar by promoting glucose uptake into skeletal muscle and fat.
it furthermore enhances protein synthesis and decreases lipolysis and proteolysis..

consult your doctor immediately if you missed the dose of eglucent injection..

• take this medicine 15 minutes before a meal or within 20 minutes after beginning a meal • this medicine is prescribed to regulate blood sugar levels in type 1 and type 2 diabetic patients • this medicine helps very rapidly and remains shorter duration than soluble insulin (2 to 5 hours) • avoid alcohol consumption while using this medicine • tell your doctor if you are pregnant or intend to be pregnant or breastfeeding • along with this medication, follow healthy lifestyle changes like exercise daily, eat a low and carbohydrate diet • do not take excess dose than recommended by your physician. • do not discontinue this medicine without informing your doctor..

major • balofloxacin + eglucent: concurrent use of these medications may result in an increased risk of hypoglycaemia or hyperglycaemia • ciprofloxacin + eglucent: concurrent use of these medications may result in an increased risk of hypoglycaemia or hyperglycaemia • levofloxacin + eglucent: concurrent use of these medications may result in an increased risk of hypoglycaemia or hyperglycaemia moderate • acarbose + eglucent: concurrent use of these medications may result in an increased risk of hypoglycaemia • amiloride + eglucent: concurrent use of these medications may result in hypoglycaemia and decreased effectiveness of eglucent • aspirin + eglucent: concurrent use of these medications may result in an increased risk of hypoglycaemia • atazanavir + eglucent: concurrent use of these medications may result in hypoglycaemia and decreased effectiveness of eglucent • betaxolol + eglucent: concurrent use of these medications may result in an increased risk of hypoglycaemia or hyperglycaemia • captopril + eglucent: concurrent use of these medications may result in an increased risk of hypoglycaemia.